HLB Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 19, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	265,789	934,494	331,363	365,136	378,914	776,712
Market Cap Growth	-67.36%	182.02%	-9.25%	-3.64%	-51.22%	0.46%
Enterprise Value	284,525	946,064	315,400	359,859	380,861	785,427
Last Close Price	3015.00	10621.32	3977.32	4907.60	5990.56	12362.14
PS Ratio	4.20	17.01	6.30	8.61	8.69	18.09
PB Ratio	1.57	5.14	1.93	2.85	2.91	7.74
P/TBV Ratio	4.96	6.37	2.21	3.28	3.31	9.64
P/FCF Ratio	55.11	1435.95	109.54	-	-	-
P/OCF Ratio	43.45	725.68	99.60	-	-	-
EV/Sales Ratio	4.50	17.22	6.00	8.49	8.74	18.30
EV/EBITDA Ratio	-	2022.13	-	-	-	-
EV/FCF Ratio	59.00	1453.73	104.26	-	-	-
Debt / Equity Ratio	0.13	0.13	0.06	0.41	0.39	0.13
Debt / EBITDA Ratio	-	49.91	-	-	-	-
Debt / FCF Ratio	4.59	35.88	3.31	-	-	-
Net Debt / Equity Ratio	-0.03	-0.08	-0.13	-0.09	-0.38	-0.15
Net Debt / EBITDA Ratio	2.71	-30.82	57.35	2.03	5.27	1.46
Net Debt / FCF Ratio	-0.94	-22.16	-7.38	0.97	4.09	1.32
Asset Turnover	0.29	0.26	0.27	0.23	0.28	0.33
Inventory Turnover	8.06	8.40	7.70	7.66	13.82	11.14
Quick Ratio	0.92	1.46	1.58	1.24	1.91	1.82
Current Ratio	1.16	1.70	1.86	1.37	2.00	2.07
Return on Equity (ROE)	-4.97%	-12.97%	-1.98%	-8.97%	-15.42%	-19.73%
Return on Assets (ROA)	-2.22%	-2.27%	-2.85%	-2.49%	-4.45%	-5.39%
Return on Capital Employed (ROCE)	-4.20%	-4.10%	-5.10%	-5.80%	-8.30%	-10.90%
Earnings Yield	-3.01%	-2.44%	-0.69%	-3.11%	-4.54%	-2.18%
FCF Yield	1.81%	0.07%	0.91%	-3.34%	-3.19%	-1.51%
Buyback Yield / Dilution	-2.60%	-6.36%	-14.46%	-10.86%	-7.26%	-4.63%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.